
Keywords: کانابیدیول; Cannabis sativa L. chemotypes; Standardized extracts; Non-psychotropic phytocannabinoids; Aldose reductase inhibitory activity; Molecular docking study; ALR2; aldose reductase; ARIs; aldose reductase inhibitors; â9-THC; â9-tetrahydrocannabinol; CBD; c